Search By

Format
Articles (118)Events (13)News (1059)Interviews (77)
Publication Date

1,059 Results

Search By

ArticlesEventsNewsInterviews

new auth way

s simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library in London, took a 1914 Cicero translation and scrambled it to make

Ankit Kankar | Jun 20, 2026

Research & development

& kedar

Samie Ahmed | May 19, 2026

Cipla Gains First AB-Rated gVentolin Approval in U.S. Respiratory Generics Market

Cipla secures the first AB-rated gVentolin approval in the U.S., clearing the FDA's complex pMDI equivalence threshold while posting record FY26 revenue.

Michael Bani | May 15, 2026

Alembic Pharma Gains USFDA Tentative Approval for Darolutamide Tablets in U.S. Oncology Market

Alembic Pharma secures USFDA tentative approval for Darolutamide Tablets 300 mg, targeting a $3.155B U.S. oncology generic market.

Michael Bani | May 15, 2026

Indoco Remedies Gains EU GMP Certification for Baddi Plant from Malta Medicines Authority

Indoco Remedies' Baddi plant receives EU GMP certification from Malta Medicines Authority after a five-day inspection in early 2026.

Michael Bani | May 15, 2026

Lupin Gains FDA Approval for Famotidine Injection USP Manufactured at Nagpur Facility

Lupin's Nagpur facility secures USFDA approval for Famotidine Injection USP, a generic of Pepcid injection, for the U.S. market.

Michael Bani | May 15, 2026

Fortress Biotech Gains FDA Approval for ZYCUBO® and Closes $205M PRV Sale in Q1 2026

Fortress Biotech's Cyprium closed a $205M PRV sale in Q1 2026 following FDA approval of ZYCUBO® for Menkes disease in pediatric patients.

Michael Bani | May 15, 2026